Astellas Pharma Inc
F:YPHA
Astellas Pharma Inc
F:YPHA
Price:
11.8
EUR
Market Closed
Market Cap:
21.1B
EUR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
YPHA Alert
Astellas Pharma Inc
11.8
0.0 (0%)
| 52 Week Range |
7.5
11.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
Delete Alert
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Astellas Pharma Inc
Astellas Pharma Inc
| Current Assets | 1.4T |
| Cash & Short-Term Investments | 295.7B |
| Receivables | 716.4B |
| Other Current Assets | 356.7B |
| Non-Current Assets | 2.1T |
| Long-Term Investments | 130.3B |
| PP&E | 334.2B |
| Intangibles | 1.5T |
| Other Non-Current Assets | 162.9B |
| Current Liabilities | 1.3T |
| Accounts Payable | 168.7B |
| Other Current Liabilities | 1.2T |
| Non-Current Liabilities | 512.4B |
| Long-Term Debt | 320B |
| Other Non-Current Liabilities | 192.4B |
Balance Sheet
Astellas Pharma Inc
Astellas Pharma Inc
Currency: JPY
| Mar-2002 | Mar-2003 | Mar-2004 | Mar-2005 | Mar-2006 | Mar-2007 | Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
203 352
|
230 434
|
276 722
|
374 062
|
178 107
|
223 398
|
248 527
|
267 460
|
312 196
|
142 895
|
210 986
|
233 814
|
275 572
|
348 343
|
346 879
|
331 801
|
328 669
|
297 477
|
313 126
|
326 128
|
315 986
|
376 840
|
335 687
|
188 372
|
|
| Cash Equivalents |
203 352
|
230 434
|
276 722
|
374 062
|
178 107
|
223 398
|
248 527
|
267 460
|
312 196
|
142 895
|
210 986
|
233 814
|
275 572
|
348 343
|
346 879
|
331 801
|
328 669
|
297 477
|
313 126
|
326 128
|
315 986
|
376 840
|
335 687
|
188 372
|
|
| Short-Term Investments |
136 364
|
103 190
|
69 013
|
55 793
|
445 358
|
284 355
|
293 582
|
246 463
|
225 078
|
33 908
|
88 112
|
78 862
|
119 757
|
48 226
|
13 641
|
9 122
|
3 062
|
13 597
|
11 817
|
0
|
2 281
|
106
|
93
|
1 504
|
|
| Total Receivables |
115 928
|
121 517
|
119 687
|
127 869
|
226 674
|
230 508
|
221 416
|
221 962
|
226 438
|
261 117
|
261 800
|
284 142
|
370 668
|
399 749
|
358 106
|
334 357
|
341 441
|
365 348
|
373 505
|
362 722
|
423 018
|
465 455
|
576 726
|
674 653
|
|
| Accounts Receivables |
115 928
|
121 517
|
119 687
|
127 869
|
226 674
|
230 508
|
221 416
|
221 962
|
226 438
|
261 117
|
261 800
|
284 142
|
308 405
|
332 923
|
327 599
|
309 817
|
319 512
|
342 628
|
347 042
|
343 178
|
382 462
|
427 965
|
534 985
|
632 525
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
62 263
|
66 826
|
30 507
|
24 540
|
21 929
|
22 720
|
26 463
|
19 544
|
40 556
|
37 490
|
41 741
|
42 128
|
|
| Inventory |
50 091
|
56 592
|
56 738
|
40 460
|
93 863
|
90 979
|
91 444
|
105 429
|
111 052
|
116 880
|
111 821
|
128 178
|
135 228
|
156 907
|
161 691
|
182 537
|
147 626
|
151 511
|
151 017
|
164 080
|
153 072
|
174 386
|
248 738
|
297 261
|
|
| Other Current Assets |
45 637
|
47 166
|
56 898
|
59 281
|
106 302
|
136 743
|
122 306
|
122 324
|
113 777
|
98 351
|
108 359
|
102 193
|
12 067
|
12 733
|
17 220
|
18 848
|
24 821
|
29 226
|
18 049
|
19 658
|
28 997
|
33 167
|
33 486
|
39 559
|
|
| Total Current Assets |
551 372
|
558 899
|
579 058
|
657 465
|
1 050 304
|
965 983
|
977 275
|
963 638
|
988 541
|
653 151
|
781 078
|
827 189
|
913 292
|
965 958
|
897 537
|
876 665
|
845 619
|
857 159
|
867 514
|
872 588
|
923 354
|
1 049 954
|
1 194 730
|
1 201 349
|
|
| PP&E Net |
197 116
|
190 570
|
174 118
|
134 672
|
206 564
|
194 553
|
179 880
|
181 446
|
184 486
|
190 157
|
199 159
|
218 478
|
191 451
|
202 869
|
200 955
|
191 115
|
181 295
|
173 483
|
268 600
|
264 623
|
269 044
|
286 459
|
293 742
|
328 921
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
191 451
|
202 869
|
200 955
|
191 115
|
181 295
|
173 483
|
268 600
|
264 623
|
269 044
|
286 459
|
293 742
|
328 921
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
258 588
|
269 258
|
279 641
|
278 073
|
283 414
|
274 762
|
295 586
|
327 707
|
355 010
|
374 379
|
395 737
|
409 402
|
|
| Intangible Assets |
36 429
|
31 498
|
27 266
|
14 670
|
31 515
|
41 511
|
38 670
|
31 984
|
40 601
|
265 922
|
220 086
|
198 864
|
280 120
|
295 844
|
339 202
|
387 419
|
416 912
|
429 707
|
724 773
|
651 427
|
623 431
|
562 496
|
1 453 824
|
1 123 714
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
29 318
|
26 377
|
22 159
|
101 255
|
94 192
|
95 977
|
116 766
|
136 337
|
150 660
|
168 521
|
212 976
|
225 864
|
278 253
|
284 011
|
303 030
|
328 411
|
418 694
|
415 207
|
|
| Note Receivable |
711
|
577
|
496
|
1 676
|
2 386
|
2 286
|
0
|
0
|
0
|
0
|
0
|
0
|
11 390
|
26 511
|
35 631
|
32 684
|
36 027
|
34 912
|
46 570
|
45 188
|
40 666
|
32 793
|
27 762
|
25 042
|
|
| Long-Term Investments |
57 974
|
54 364
|
67 605
|
59 466
|
242 162
|
210 694
|
157 773
|
89 562
|
70 797
|
60 204
|
60 525
|
61 646
|
85 392
|
101 190
|
80 383
|
54 178
|
59 780
|
75 462
|
66 399
|
91 704
|
91 009
|
101 955
|
116 659
|
118 596
|
|
| Other Long-Term Assets |
53 341
|
62 252
|
54 148
|
45 605
|
51 583
|
55 668
|
56 229
|
55 431
|
57 583
|
64 394
|
45 589
|
43 407
|
54 697
|
64 869
|
94 970
|
103 490
|
105 596
|
101 061
|
63 060
|
64 087
|
81 861
|
94 450
|
64 192
|
126 715
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
29 318
|
26 377
|
22 159
|
101 255
|
94 192
|
95 977
|
116 766
|
136 337
|
150 660
|
168 521
|
212 976
|
225 864
|
278 253
|
284 011
|
303 030
|
328 411
|
418 694
|
415 207
|
|
| Total Assets |
896 943
N/A
|
898 160
+0%
|
902 691
+1%
|
913 554
+1%
|
1 584 514
+73%
|
1 470 695
-7%
|
1 439 145
-2%
|
1 348 438
-6%
|
1 364 167
+1%
|
1 335 083
-2%
|
1 400 629
+5%
|
1 445 561
+3%
|
1 653 108
+14%
|
1 793 578
+8%
|
1 799 338
+0%
|
1 814 072
+1%
|
1 858 205
+2%
|
1 897 648
+2%
|
2 315 169
+22%
|
2 273 628
-2%
|
2 332 395
+3%
|
2 456 518
+5%
|
3 569 603
+45%
|
3 339 544
-6%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
54 821
|
41 231
|
37 572
|
31 227
|
62 507
|
73 018
|
70 046
|
89 769
|
84 024
|
88 601
|
108 408
|
102 834
|
187 032
|
226 602
|
181 559
|
182 826
|
140 909
|
185 280
|
171 954
|
124 777
|
130 739
|
140 236
|
185 193
|
187 840
|
|
| Accrued Liabilities |
23 611
|
28 074
|
23 809
|
22 873
|
51 949
|
67 833
|
58 534
|
52 686
|
64 939
|
74 521
|
82 404
|
94 460
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
1 483
|
1 887
|
1 237
|
0
|
414
|
1 671
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
326 000
|
120 000
|
140 000
|
75 000
|
420 393
|
184 874
|
|
| Current Portion of Long-Term Debt |
14 915
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 062
|
1 339
|
1 505
|
499
|
444
|
430
|
18 105
|
16 101
|
17 730
|
13 546
|
66 829
|
97 994
|
|
| Other Current Liabilities |
61 521
|
76 375
|
47 523
|
65 343
|
185 327
|
166 308
|
155 945
|
141 094
|
128 190
|
76 522
|
123 358
|
116 242
|
152 594
|
192 949
|
230 295
|
216 531
|
280 267
|
311 955
|
282 649
|
331 494
|
398 942
|
497 252
|
613 310
|
590 902
|
|
| Total Current Liabilities |
156 351
|
147 567
|
110 141
|
119 443
|
300 197
|
308 830
|
284 525
|
283 549
|
277 153
|
239 644
|
314 170
|
313 536
|
340 688
|
420 890
|
413 359
|
399 856
|
421 620
|
497 665
|
798 708
|
592 372
|
687 411
|
726 034
|
1 285 725
|
1 061 610
|
|
| Long-Term Debt |
8 397
|
7 336
|
6 824
|
5 020
|
561
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
749
|
626
|
722
|
28 389
|
49 422
|
52 882
|
129 272
|
142 163
|
55 014
|
111 461
|
518 494
|
654 219
|
|
| Deferred Income Tax |
4 760
|
4 785
|
2 418
|
2 295
|
1 408
|
583
|
257
|
0
|
0
|
42 248
|
30 932
|
34 715
|
2
|
2
|
0
|
18 514
|
26 426
|
5 175
|
24 670
|
18 161
|
5 823
|
6 048
|
51 346
|
5 353
|
|
| Minority Interest |
2 854
|
2 408
|
2 462
|
1 578
|
443
|
351
|
328
|
338
|
352
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
58 516
|
57 293
|
55 453
|
43 327
|
65 009
|
62 288
|
43 501
|
34 670
|
33 084
|
32 097
|
37 404
|
35 285
|
43 193
|
54 108
|
126 048
|
95 503
|
92 448
|
83 530
|
73 351
|
134 817
|
123 839
|
105 021
|
118 050
|
105 107
|
|
| Total Liabilities |
230 878
N/A
|
219 389
-5%
|
177 298
-19%
|
171 663
-3%
|
367 618
+114%
|
372 052
+1%
|
328 611
-12%
|
318 557
-3%
|
310 589
-3%
|
313 989
+1%
|
382 506
+22%
|
383 536
+0%
|
384 632
+0%
|
475 662
+24%
|
540 129
+14%
|
542 262
+0%
|
589 916
+9%
|
639 252
+8%
|
1 026 001
+61%
|
887 513
-13%
|
872 087
-2%
|
948 564
+9%
|
1 973 615
+108%
|
1 826 289
-7%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
99 744
|
99 760
|
99 760
|
100 490
|
102 985
|
103 000
|
103 000
|
103 000
|
103 000
|
103 000
|
103 000
|
103 000
|
103 001
|
103 001
|
103 001
|
103 001
|
103 001
|
103 001
|
103 001
|
103 001
|
103 001
|
103 001
|
103 001
|
103 001
|
|
| Retained Earnings |
515 831
|
566 088
|
616 112
|
640 517
|
959 217
|
1 006 932
|
917 841
|
958 240
|
896 306
|
875 873
|
896 341
|
919 447
|
864 830
|
905 083
|
973 054
|
1 015 707
|
977 553
|
993 084
|
906 750
|
954 034
|
944 891
|
908 694
|
809 776
|
741 237
|
|
| Additional Paid In Capital |
113 668
|
113 684
|
113 684
|
114 414
|
176 806
|
176 821
|
176 821
|
176 821
|
176 821
|
176 821
|
176 821
|
176 821
|
176 822
|
176 822
|
176 903
|
177 091
|
177 219
|
177 301
|
177 506
|
177 830
|
179 467
|
181 280
|
184 070
|
185 259
|
|
| Unrealized Security Profit/Loss |
7 359
|
4 757
|
13 848
|
11 599
|
44 252
|
38 085
|
27 852
|
10 018
|
14 153
|
9 479
|
12 257
|
15 966
|
28 588
|
28 588
|
29 103
|
14 629
|
18 289
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
69 702
|
101 416
|
101 456
|
114 038
|
61 982
|
241 919
|
104 122
|
155 295
|
54 160
|
23 492
|
23 131
|
72 284
|
54 535
|
86 997
|
157 111
|
138 207
|
135 951
|
164 629
|
7 178
|
15 377
|
13 934
|
25 123
|
33 783
|
37 524
|
|
| Other Equity |
834
|
4 102
|
16 557
|
11 090
|
4 382
|
15 722
|
10 860
|
62 904
|
82 542
|
120 587
|
147 165
|
80 925
|
149 770
|
179 546
|
134 259
|
99 589
|
128 178
|
149 639
|
109 089
|
166 627
|
246 883
|
340 102
|
532 924
|
521 282
|
|
| Total Equity |
666 066
N/A
|
678 771
+2%
|
725 391
+7%
|
741 892
+2%
|
1 216 896
+64%
|
1 098 641
-10%
|
1 110 532
+1%
|
1 029 880
-7%
|
1 053 578
+2%
|
1 021 094
-3%
|
1 018 123
0%
|
1 062 025
+4%
|
1 268 476
+19%
|
1 317 916
+4%
|
1 259 209
-4%
|
1 271 810
+1%
|
1 268 289
0%
|
1 258 396
-1%
|
1 289 168
+2%
|
1 386 115
+8%
|
1 460 308
+5%
|
1 507 954
+3%
|
1 595 988
+6%
|
1 513 255
-5%
|
|
| Total Liabilities & Equity |
896 944
N/A
|
898 160
+0%
|
902 689
+1%
|
913 555
+1%
|
1 584 514
+73%
|
1 470 693
-7%
|
1 439 143
-2%
|
1 348 437
-6%
|
1 364 167
+1%
|
1 335 083
-2%
|
1 400 629
+5%
|
1 445 561
+3%
|
1 653 108
+14%
|
1 793 578
+8%
|
1 799 338
+0%
|
1 814 072
+1%
|
1 858 205
+2%
|
1 897 648
+2%
|
2 315 169
+22%
|
2 273 628
-2%
|
2 332 395
+3%
|
2 456 518
+5%
|
3 569 603
+45%
|
3 339 544
-6%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
1 806
|
1 655
|
1 655
|
1 641
|
2 792
|
2 572
|
2 490
|
2 350
|
2 309
|
2 309
|
2 310
|
2 256
|
2 231
|
2 193
|
2 125
|
2 065
|
1 976
|
1 886
|
1 858
|
1 853
|
1 827
|
1 797
|
1 793
|
1 790
|
|
Switch to:
Switch to:
See Also
Discover More
